I expect the interview with Frank Ng, the inventor of Metabolic Pharmaceuticals obesity and type 2 diabetes drugs, which should appear on George Negus’s program on ABC TV tonight at 6:30 pm, will give the share price a further boost in the coming days.
The latest Shares magazine issue recommends MBP/MBPO as a top 10 share buy for 2003. http://www.sharesmag.com.au/stories2/20030201/17600.asp
Also the results from recent phase 2a obesity drug trial are due to be released to the public before the end of the month and the very important major weight loss trial is due to commence mid year.
All the above news should see more interest in the stock and in Circadian Technologies CIR which owns 34% of Metabolic Pharmaceuticals.
MBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held